Wagner, Nikolaus B
Forschner, Andrea
Leiter, Ulrike
Garbe, Claus
Eigentler, Thomas K
Article History
Received: 16 February 2018
Revised: 7 June 2018
Accepted: 7 June 2018
First Online: 28 June 2018
Ethics approval and consent to participate
: This study has been performed in accordance with the Declaration of Helsinki and had been approved by the Ethics Committee of University Hospital Tuebingen (reference number 436/2017BO2). Written informed consent was obtained from all subjects.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.
: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
: Nikolaus Benjamin Wagner received travel support from Novartis. Andrea Forschner reports honoraria as a speaker from BMS, MSD, Roche and Novartis. She is advisory board member of Roche and Novartis and received travel support from Roche, Novartis and BMS. Ulrike Leiter declares no conflict of interest. Claus Garbe reports grants and personal fees from BMS during the conduct of the study; grants and personal fees from Roche, Novartis and personal fees from Amgen, MSD and Philogen outside the submitted work. Thomas Kurt Eigentler reports honoraria as a speaker from BMS. He is advisory board member of BMS, Roche and Novartis.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).